FDA approves first drug for tumors tied to breast cancer genes

(Reuters) - The U.S. Food and Drug Administration said on Friday it has approved expanded use of AstraZeneca Plc's cancer drug Lynparza to include patients with metastatic breast cancer whose disease is associated with a mutation of the BRCA gene.

FDA approves first drug for tumors tied to breast cancer genes

(HealthDay)—The U.S. Food and Drug Administration on Friday approved the first drug aimed at treating metastatic breast cancers linked to the BRCA gene mutation.

Fri 12 Jan 18 from Medical Xpress

US OKs 1st drug aimed at women with inherited breast cancer

U.S. regulators have approved the first drug aimed at women with advanced breast cancer caused by an inherited flawed gene....

Fri 12 Jan 18 from AP

US OKs 1st drug aimed at women with inherited breast cancer, Fri 12 Jan 18 from AP

FDA approves expanded use of AstraZeneca cancer drug

(Reuters) - The U.S. Food and Drug Administration said on Friday it has approved expanded use of AstraZeneca Plc's cancer drug Lynparza to include patients with metastatic breast cancer whose ...

Fri 12 Jan 18 from Reuters

U.S. FDA approves expanded use of AstraZeneca breast cancer drug, Fri 12 Jan 18 from Reuters

Olaparib OK'd for Metastatic Breast Ca with Mutated BRCA

(MedPage Today) -- First PARP inhibitor to win breast cancer indication

Fri 12 Jan 18 from MedPageToday

  • Pages: 1

Bookmark

Bookmark and Share